Steve Clifford
Steve Clifford
Director, Newcastle University Centre for Cancer
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
PH Maxwell, MS Wiesener, GW Chang, SC Clifford, EC Vaux, ...
Nature 399 (6733), 271-275, 1999
51831999
Molecular subgroups of medulloblastoma: the current consensus
MD Taylor, PA Northcott, A Korshunov, M Remke, YJ Cho, SC Clifford, ...
Acta neuropathologica 123 (4), 465-472, 2012
13542012
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman, N Masson, DR Mole, P Jaakkola, GW Chang, SC Clifford, ...
Journal of Biological Chemistry 275 (33), 25733-25741, 2000
12252000
Medulloblastoma comprises four distinct molecular variants
PA Northcott, A Korshunov, H Witt, T Hielscher, CG Eberhart, S Mack, ...
Journal of clinical oncology 29 (11), 1408, 2011
11282011
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ...
Acta neuropathologica 123 (4), 473-484, 2012
7732012
Dissecting the genomic complexity underlying medulloblastoma
DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ...
Nature 488 (7409), 100-105, 2012
7192012
Subtypes of medulloblastoma have distinct developmental origins
P Gibson, Y Tong, G Robinson, MC Thompson, DS Currle, C Eden, ...
Nature 468 (7327), 1095-1099, 2010
7032010
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ...
PloS one 3 (8), e3088, 2008
7002008
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
PA Northcott, DJH Shih, J Peacock, L Garzia, AS Morrissy, T Zichner, ...
Nature 488 (7409), 49-56, 2012
6642012
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ...
Acta neuropathologica 121 (3), 381-396, 2011
4452011
β-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison, OE Onilude, JC Lindsey, ME Lusher, CL Weston, RE Taylor, ...
Journal of Clinical Oncology 23 (31), 7951-7957, 2005
4342005
Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
SC Clifford, ME Cockman, AC Smallwood, DR Mole, ER Woodward, ...
Human molecular genetics 10 (10), 1029-1038, 2001
4112001
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ...
Journal of Clinical Oncology 31 (23), 2927, 2013
3082013
Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL‐independent …
SC Clifford, AH Prowse, NA Affara, CHCM Buys, ER Maher
Genes, Chromosomes and Cancer 22 (3), 200-209, 1998
3071998
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables
DW Ellison, M Kocak, J Dalton, H Megahed, ME Lusher, SL Ryan, W Zhao, ...
Journal of clinical oncology 29 (11), 1400, 2011
2952011
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ...
Acta Neuropathologica, 2016
2802016
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
UK Tyne
Cell Cycle 5 (22), 2666-2670, 2006
2612006
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients
JM Lamont, CS McManamy, AD Pearson, SC Clifford, DW Ellison
Clinical Cancer Research 10 (16), 5482-5493, 2004
2402004
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ...
Journal of clinical oncology 30 (26), 3187-3193, 2012
2372012
Cytogenetic prognostication within medulloblastoma subgroups
DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ...
Journal of clinical oncology 32 (9), 886, 2014
2302014
The system can't perform the operation now. Try again later.
Articles 1–20